Robert G. Shawah's most recent trade in Acurx Pharmaceuticals Inc was a trade of 145,500 Stock Option done . Disclosure was reported to the exchange on Feb. 5, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Acurx Pharmaceuticals Inc | Robert G. Shawah | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 145,500 | 145,500 | - | - | Stock Option | |
Acurx Pharmaceuticals Inc | Robert G. Shawah | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 145,000 | 145,000 | - | - | Stock Option | |
Acurx Pharmaceuticals Inc | Robert G. Shawah | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2021 | 200,000 | 200,000 | - | - | Stock Option | |
Acurx Pharmaceuticals Inc | Robert G. Shawah | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2021 | 70,000 | 70,000 | - | - | Stock Option |